Lexicon Pharmaceuticals
Top stories
Latest
- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Receives Average Rating of "Hold" from Brokeragestickerreport.com · 2026-10-03 07:53 UTC · story
- Cantor Fitzgerald Begins Coverage on Lexicon Pharmaceuticals (NASDAQ:LXRX)tickerreport.com · 2026-09-30 05:40 UTC · story